SupplementaryFigure1. Nucleotide sequence homology between the transcripts for the 4 isoforms of human UTR of L and S transcripts were non-homologous and at least 17bps of the S-transcript, from the ATG site, was also non-homologous; primers were thus designed from this non-homologous region to detect DCLK1-S transcripts, and the specific sense and anti-sense primers used for detecting either the L isoform or the S isoform are presented in SupplementaryTable1. Sense and anti-sense primers were similarly designed from non- which were generated against a peptide sequence between 700-729 bp of isoform 1 (DCLK1-L), which is homologous to C-terminal end of isoform 2 (DCLK1-S), but is not homologous to isoforms 3 and 4. Since we now know the normal and cancer epithelial cells, examined in here, only express isoforms 1 (L) and 2 (S), the commercially available antibodies detect both these isoforms, which differ in molecular mass: L= ~82 kDa; S= ~47kDa. SupplementaryFigure5. Relative expression levels of long and short transcripts of DCLK1-isoforms in patient samples. Total RNA from indicated tissue samples were amplified by RT-PCR by using sense and anti-sense primers for amplifying either DCLK1-L transcripts or DCLK1-S transcripts, as described in Methods.
SupplementaryFigure3
Representative data are presented from normal colons, tubular adenomas (TA) and advanced adenocarcinomas (AdCAs), obtained from two patients each; the samples were co-amplified and co-run at the same time for L/S transcripts and corresponding β-actin levels. Densitometric data from all samples that were similarly analyzed are presented as a ratio of β-actin levels in the corresponding samples, and are presented as bar-graphs in 
Supplementary Table 1 Primer Sequences Used for RT-PCR/qRT-PCR And Other Assays

SupplementaryTable2. Relative Expression Of DCLK1-L/S In Normal Colonic Mucosa Samples From 22
Patients By Western Blot Analysis. Normal colonic mucosa samples were collected from a total of 22 patients, free of adenocarcinomas, as described under methods. Relative band density in the western blots of normal colonic mucosa samples was analyzed using Image J, as described in Methods. Samples which expressed similar concentrations as HEK293 cells, used as positive control, were arbitrarily grouped under DCLK1-L high expression; samples which expressed less than 50% of that in HEK293 cells were arbitrarily grouped as DCLK1-L low expression; samples with no detectable expression, similar to that in HCT116 cells were labeled DCLK1-L No expression. Levels of DCLK1-S expression were quantified similarly, but HCT116 cells were used as a positive control, and HEK293 ce4lls were used as a negative control. Only one normal colon mucosal sample from patient 262, appeared to be negative for both S/L isoforms, which could be due to possible degradation of the sample, since samples after endoscopic collection, are usually flash frozen within 5min, but due to logistics can remain at room temperature for longer than 10 min, before flash freezing, as described.
RT-PCR analysis of long and short transcript of DCLK1 in human colon cancer cell lines SupplementaryTable4. Clinicopathological variables and DCLK1-S expression in 92 colorectal cancer patients. Samples were obtained from patients with colonic adenocarcinomas at CRC stages of I-IV, from 92 patients in Japan, as described in Methods. The relative expression levels of DCLK1-S were analyzed by qRT-PCR, and high/low expression groups were classified by the median expression values in cancer tissues.
